BriaCell Therapeutics Corp
Save
6.05M
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

BriaCell Therapeutics Corp. operates as a Phase 3 biotechnology company transforming cancer care with its novel cellular immunotherapies. It is conducting a pivotal Phase 3 clinical trial in advanced breast cancer with its Bria-IMT in combination with an immune check point inhibitor. It is also developing personalized off-the-shelf treatments for breast cancer, prostate cancer, and other cancers.

Similar securities

Based on sector and market capitalization

Report issue